Genentech

LUCENTIS

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / LUCENTIS – J2778

Manufacturer:

Genentech

Name:

LUCENTIS

HCPCS Code Descriptor:

Injection, ranibizumab, 0.1 mg

Category:

J Code

HCPCS:

J2778

NDC(s):

50242-0082-03, 50242-0080-02, 50242-0080-03, 50242-0082-02

Primary Type:

Opthalmic

Generic Status:

Single-Source

Route of Administration:

Intraocular

About:

LUCENTIS is an Opthalmic drug manufactured by Genentech and administered via the Intraocular route of administration. The J Code: J2778 is aligned to the drug LUCENTIS.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/08

HCPCS Effective Date:

1/1/08

HCPCS Short Description:

Ranibizumab injection

Billing and Coding Guide:

https://www.lucentis.com/content/dam/gene/accesssolutions/pdfs/coding/LUCENTIS-Billing-Coding-for-ALL.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation